Literature DB >> 2910076

Pulmonary function as a predictor of coronary heart disease.

E B Marcus1, J D Curb, C J MacLean, D M Reed, K Yano.   

Abstract

The role of pulmonary function as an independent predictor of coronary heart disease was examined in 1965-1983 in a cohort of Japanese-American men. As part of the Honolulu Heart Program, the authors measured pulmonary function in 5,924 men aged 45-68 years who were free of coronary heart disease at baseline examination and followed them for 15-18 years for the development of nonfatal myocardial infarction and fatal coronary heart disease. Per cent predicted forced expiratory volume in one second (%PFEV1) was significantly inversely related to coronary heart disease incidence in the total cohort after adjusting for age (p less than 0.0001) and then for all known coronary heart disease risk factors (p = 0.0004). However, when examined by smoking status, %PFEV1 was a predictor of coronary heart disease only among past and current smokers, and not for men who had never smoked cigarettes (p = 0.36). The association between pulmonary function and coronary heart disease can be explained by cigarette smoking, which leads to both lung impairment and coronary heart disease incidence.

Entities:  

Mesh:

Year:  1989        PMID: 2910076     DOI: 10.1093/oxfordjournals.aje.a115128

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  15 in total

1.  [What can we do about the scant introduction of spirometry into primary care?].

Authors:  C García Benito; F García Río
Journal:  Aten Primaria       Date:  2004-03-31       Impact factor: 1.137

2.  Ventilatory function, height, and mortality among lifelong non-smokers.

Authors:  D P Strachan
Journal:  J Epidemiol Community Health       Date:  1992-02       Impact factor: 3.710

3.  Impact of lung-function measures on cardiovascular disease events in older adults with metabolic syndrome and diabetes.

Authors:  Hwa Mu Lee; Yanglu Zhao; Michael A Liu; David Yanez; Mercedes Carnethon; R Graham Barr; Nathan D Wong
Journal:  Clin Cardiol       Date:  2018-07-17       Impact factor: 2.882

4.  Decline in lung function and mortality: the Busselton Health Study.

Authors:  G Ryan; M W Knuiman; M L Divitini; A James; A W Musk; H C Bartholomew
Journal:  J Epidemiol Community Health       Date:  1999-04       Impact factor: 3.710

5.  Shared and distinct genetic influences among different measures of pulmonary function.

Authors:  Terrie Vasilopoulos; Michael D Grant; Carol E Franz; Matthew S Panizzon; Hong Xian; Rosemary Toomey; Michael J Lyons; William S Kremen; Kristen C Jacobson
Journal:  Behav Genet       Date:  2013-01-09       Impact factor: 2.805

6.  Individual differences in cognitive ability at age 20 predict pulmonary function 35 years later.

Authors:  Terrie Vasilopoulos; William S Kremen; Michael D Grant; Matthew S Panizzon; Hong Xian; Rosemary Toomey; Michael J Lyons; Kristen C Jacobson; Carol E Franz
Journal:  J Epidemiol Community Health       Date:  2014-10-01       Impact factor: 3.710

7.  The importance of lung function, non-malignant diseases associated with asbestos, and symptoms as predictors of ischaemic heart disease in shipyard workers exposed to asbestos.

Authors:  A Sandén; B Järvholm; S Larsson
Journal:  Br J Ind Med       Date:  1993-09

8.  Spirometric impairments, cardiovascular outcomes, and noncardiovascular death in older persons.

Authors:  Carlos A Vaz Fragoso; Peter H Van Ness; Terrence E Murphy; Gail J McAvay
Journal:  Respir Med       Date:  2018-02-27       Impact factor: 3.415

9.  Age at asthma onset and subsequent asthma outcomes among adults with active asthma.

Authors:  Maria C Mirabelli; Suzanne F Beavers; Arjun B Chatterjee; Jeanne E Moorman
Journal:  Respir Med       Date:  2013-10-05       Impact factor: 3.415

10.  FEV1 as a Standalone Spirometric Predictor and the Attributable Fraction for Death in Older Persons.

Authors:  Carlos A Vaz Fragoso; Peter H Van Ness; Gail J McAvay
Journal:  Respir Care       Date:  2019-10-29       Impact factor: 2.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.